Verition Fund Management
GH icon

Verition Fund Management’s Guardant Health GH Stock Holding History

Verition Fund Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.96M Sell
21,210
-221
-1% -$22.2K 0.01% 1032
2025
Q4 		$2.19M Sell
21,431
-4,219
-16% -$377K 0.01% 1524
2025
Q3 		$1.6M Sell
25,650
-9,493
-27% -$516K 0.01% 2158
2025
Q2 		$1.83M Sell
35,143
-23,050
-40% -$1.03M 0.01% 2022
2025
Q1 		$2.48M Sell
58,193
-36,090
-38% -$1.56M 0.01% 1423
2024
Q4 		$2.88M Buy
94,283
+56,642
+150% +$1.59M 0.01% 1302
2024
Q3 		$863K Buy
37,641
+25,900
+221% +$733K ﹤0.01% 1983
2024
Q2 		$339K Sell
11,741
-15,131
-56% -$352K ﹤0.01% 2273
2024
Q1 		$554K Buy
26,872
+13,791
+105% +$296K ﹤0.01% 1955
2023
Q4 		$354K Buy
13,081
+1,340
+11% +$35.1K ﹤0.01% 1703
2023
Q3 		$348K Hold
11,741
– – ﹤0.01% 1639
2023
Q2 		$420K Sell
11,741
-17,000
-59% -$488K 0.01% 1334
2023
Q1 		$674K Buy
28,741
+20,098
+233% +$574K 0.01% 1095
2022
Q4 		$235K Buy
+8,643
New +$395K ﹤0.01% 1641
2021
Q3 		– Sell
-2,558
Closed -$318K – 2059
2021
Q2 		$318K Buy
+2,558
New +$344K ﹤0.01% 1312
2020
Q4 		– Sell
-2,046
Closed -$229K – 1201
2020
Q3 		$229K Buy
+2,046
New +$187K ﹤0.01% 891

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verition Fund Management's GH Position: Q1 2026 in Review

Verition Fund Management reduced its Guardant Health (GH) stake by 1% in Q1 2026, selling an estimated $22.2K and leaving 21,210 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #1032.

Verition Fund Management first reported a position in GH in Q3 2020 and has held it in 16 quarters since. The position peaked at $2.88M in Q4 2024. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Verition Fund Management held 21,210 shares of Guardant Health worth $1.96M as of Q1 2026.
  • Verition Fund Management sold 221 Guardant Health shares in Q1 2026, an estimated $22.2K.
  • Guardant Health made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1032 holding.
  • Verition Fund Management first reported a position in Guardant Health in Q3 2020 and has held it in 16 quarters since.
  • Verition Fund Management's Guardant Health position peaked at $2.88M in Q4 2024.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.